Showing results (81-90 of 177) with videos related to
Sort By:
Pageof 18
Neurology|November 16, 2018
Body mass index, but not vitamin D status, is associated with brain volume change in MSEllen M Mowry, Christina J Azevedo, Charles E McCulloch, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2012
Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosisAaron E Miller, Paul O'Connor, Jerry S Wolinsky, et al.Multiple Sclerosis and Related Disorders|June 14, 2019
Long-term outcomes with teriflunomide in patients with clinically isolated syndrome: Results of the TOPIC extension study★★Aaron E Miller, Patrick Vermersch, Ludwig Kappos, et al.Multiple Sclerosis and Related Disorders|May 31, 2016
Multiple sclerosis relapses are associated with increased fatigue and reduced health-related quality of life - A post hoc analysis of the TEMSO and TOWER studiesMathias Mäurer, Giancarlo Comi, Mark S Freedman, et al.Archives of Neurology|August 12, 2009
Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adultsEmmanuelle Waubant, Dorothee Chabas, Darin T Okuda, et al.JAMA Neurology|May 21, 2014
Magnetic resonance spectroscopy markers of disease progression in multiple sclerosisSara Llufriu, John Kornak, Helene Ratiney, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|November 5, 2019
Cerebellar volume loss in radiologically isolated syndromeIlena C George, Mohamed Mounir El Mendili, Matilde Inglese, et al.Journal of the Neurological Sciences|August 20, 2016
Interleukin 17 alone is not a discriminant biomarker in early demyelinating spectrum disordersChristine Lebrun, Mikael Cohen, Beatrice Pignolet, et al.Annals of Neurology|July 22, 2014
In vivo evidence of glutamate toxicity in multiple sclerosisChristina J Azevedo, John Kornak, Philip Chu, et al.Journal of Neurology|June 29, 2014
Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER studyAaron E Miller, Richard Macdonell, Giancarlo Comi, et al.Pageof 18